COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 1080: Articles 10791-10800  | Next

Identifying protein sites contributing to vaccine escape via statistical comparisons of short-term molecular dynamics simulations
Rajendran, M., Ferran, M. C., Babbitt, G. A.
10.1101/2021.12.06.471374 — Posted: 2021-12-08
PROBABILITY OF HOSPITALIZATION AND DEATH AMONG COVID-19 PATIENTS WITH COMORBIDITY DURING OUTBREAKS OCCURRING IN MEXICO CITY.
Sifuentes-Osornio, J., Angulo-Guerrero, O., de Anda-Jauregui, G., Diaz-De-Leon-Santiago, J. L., Hernandez-Lemus, E., Benitez-Perez, H., Herrera, L. A., Lopez-Arellano, O., Revuelta-Herrera, A., Rosales-Tapia, A. R., Suarez-Tapia, M., Ruiz-Gutierrez, R., Sheinbaum-Pardo, C., Kershenobich, D.
10.1101/2021.12.07.21267287 — Posted: 2021-12-08
COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Disease on Biologic Therapies; A cross-sectional study.
Shehab, M., Zurba, Y., Al Abdulsalam, A., Alfadhli, A., Elouali, S.
10.1101/2021.12.03.21267237 — Posted: 2021-12-08
Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies
Wilhelm, A., Widera, M., Grikscheit, K., Toptan, T., Schenk, B., Pallas, C., Metzler, M., Kohmer, N., Hoehl, S., Helfritz, F. A., Wolf, T., Goetsch, U., Ciesek, S.
10.1101/2021.12.07.21267432 — Posted: 2021-12-08 Discussion: Onsite
Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: a comparative analysis across two New York hospitals
Lambert, B., Stopard, I., Momeni-Boroujeni, A., Mendoza, R., Zuretti, A.
10.1101/2021.11.12.21266248 — Posted: 2021-12-08
Proactive vs. reactive country responses to the COVID19 pandemic shock
Sacco, P., Valle, F., De Domenico, M.
10.1101/2021.12.06.21267351 — Posted: 2021-12-07
Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection
Evans, J. P., Zeng, C., Carlin, C., Lozanski, G., Saif, L. J., Oltz, E. M., Gumina, R. J., Liu, S.-L.
10.1101/2021.12.06.471455 — Posted: 2021-12-07
Engineering RNA viruses with unnatural amino acid to evoke adjustable immune response in mice
Zheng, Z., Wang, Y., Wu, X., Zhang, H., Chen, H., Lin, H., Shen, Y., Xia, Q.
10.1101/2021.12.04.471206 — Posted: 2021-12-07
The Impact of Mass Exodus on the Resurgence of COVID19 Cases: Study Case of Regions in Indonesia
Nuraini, N., Sukandar, K. K., Aini, W.
10.1101/2021.12.06.21267391 — Posted: 2021-12-07
Systematic review of cardiac adverse effects in children and young people un-der 18 years of age after SARS-CoV-2 vaccination
Cruz, J., Duret, A., Harwood, R., Fraser, L. K., Jones, C. B., Ward, J., Whittaker, E., Kenny, S. E., Vinner, R. M.
10.1101/2021.12.06.21267339 — Posted: 2021-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).